**Core Concept**
The revised guidelines of the American Heart Association (AHA) for cardiac arrest management emphasize the importance of evidence-based pharmacotherapy to improve outcomes. The guidelines aim to provide a standardized approach to cardiac arrest care, including the use of medications to restore cardiac function and improve survival.

**Why the Correct Answer is Right**
The AHA guidelines recommend the use of epinephrine (adrenaline) and vasopressin in cardiac arrest management. However, amiodarone is not recommended as a first-line treatment for cardiac arrest due to its potential for pro-arrhythmic effects and lack of clear benefit in improving survival. The use of amiodarone is generally reserved for specific indications, such as atrial fibrillation or ventricular tachycardia, in the absence of cardiac arrest.

**Why Each Wrong Option is Incorrect**
**Option A:** Epinephrine is a key medication in cardiac arrest management, recommended by the AHA guidelines for its ability to restore cardiac function and improve survival.
**Option C:** Vasopressin is another medication recommended by the AHA guidelines for use in cardiac arrest, particularly in cases where epinephrine is contraindicated.

**Clinical Pearl / High-Yield Fact**
The AHA guidelines emphasize the importance of high-quality CPR and prompt defibrillation in cardiac arrest management. The use of medications should be tailored to the individual patient's needs and should not delay the initiation of CPR.

**Correct Answer: D. Amiodarone**